Masimo (MASI) Total Non-Current Liabilities (2010 - 2026)
Masimo's (MASI) quarterly Total Non-Current Liabilities came in at $771.5 million in Q2 2026, down 39.41% year-on-year from $1.3 billion in Q2 2025, and down 13.3% quarter-over-quarter from $889.9 million in Q1 2026.
Masimo (MASI) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Masimo's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $771.5 million for Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 39.41% year-over-year to $771.5 million in Q2 2026; TTM through Apr 2026 was $771.5 million, a 39.41% decrease from a year earlier, with the FY2026 full-year figure at $889.9 million, down 40.79% from the prior year.
- Total Non-Current Liabilities declined to $771.5 million in Q2 2026 per MASI's latest filing, from $889.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.7 billion in Q4 2022 and bottomed at $254.3 million in Q2 2022.
- The 5-year median for Total Non-Current Liabilities is $1.5 billion (2022), against an average of $1.3 billion.
- Across the five-year window, Total Non-Current Liabilities surged 635.1% in 2022 and plunged 40.79% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $1.7 billion in 2022, then declined by 10.83% to $1.5 billion in 2023, then fell by 2.86% to $1.5 billion in 2024, then plunged by 38.19% to $928.9 million in 2025, then fell by 16.94% to $771.5 million in 2026.
- Per Business Quant, the three latest MASI Total Non-Current Liabilities figures stand at $771.5 million (Q2 2026), $889.9 million (Q1 2026), and $928.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 771.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 771.50 Mn |
| Jan 3, 2026 | 889.90 Mn |
| Sep 27, 2025 | 928.90 Mn |
| Jun 28, 2025 | 1.28 Bn |
| Mar 29, 2025 | 1.27 Bn |
| Dec 28, 2024 | 1.50 Bn |
| Sep 28, 2024 | 1.48 Bn |
| Jun 29, 2024 | 1.39 Bn |
| Mar 30, 2024 | 1.45 Bn |
| Dec 30, 2023 | 1.55 Bn |
| Sep 30, 2023 | 1.60 Bn |
| Jul 1, 2023 | 1.58 Bn |
| Apr 1, 2023 | 1.65 Bn |
| Dec 31, 2022 | 1.74 Bn |
| Oct 1, 2022 | 1.68 Bn |
| Jul 2, 2022 | 1.47 Bn |
| Apr 2, 2022 | 254.31 Mn |
| Jan 1, 2022 | 272.80 Mn |
| Oct 2, 2021 | 228.25 Mn |
| Jul 3, 2021 | 220.03 Mn |